Combination behavioral and pharmacological interventions through telehealth platforms: Opportunities for increasing access and optimizing migraine outcomes

Documenti analoghi

• Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
  di: Jennifer Robblee, et al.
  Pubblicazione: (2024)
• Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
  di: Larry Charleston, et al.
  Pubblicazione: (2026)
• Migraine across the menopausal transition and beyond: A narrative review
  di: Tal Friedman Korn, et al.
  Pubblicazione: (2026)
• Expanding access to behavioral interventions for headache: The evolution of the Veteran Affairs behavioral medicine program in the headache centers of excellence
  di: Amy S. Grinberg
  Pubblicazione: (2025)
• Depression and anxiety are not associated with migraine outcomes in children and adolescents
  di: Amy A. Gelfand
  Pubblicazione: (2024)